Drug Discovery Services Market Size, Share, Trends, Industry Analysis Report: By Process, Type, End User, and Region

Description

List of Tables

The drug discovery services market size is expected to reach USD 75.13 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Discovery Services Market Size, Share, Trends, Industry Analysis Report: By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation), Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Drug discovery services refers to the range of research and development services provided to pharmaceutical, biotechnology, and life sciences companies to assist in the process of discovering new drug candidates. These services support various stages of drug development, including target identification, lead discovery, hit-to-lead optimization, preclinical testing, and candidate validation. Drug discovery services aim to identify potential therapeutic compounds, assess their effectiveness, and optimize their properties before moving into clinical trials.

The drug discovery services market is experiencing significant growth driven by factors such as the increasing complexity of drug development, the rising prevalence of chronic diseases, and the growing demand for innovative therapeutics. Outsourcing research activities to Contract Research Organizations (CROs) has become a key trend, as it allows pharmaceutical and biotechnology companies to reduce costs and accelerate drug development.

Advancements in technologies such as artificial intelligence, machine learning, and CRISPR gene editing are revolutionizing drug discovery processes, enabling faster and more efficient identification of potential drug candidates. Opportunities lie in the expanding fields of personalized medicine, biologics, and gene therapies, which are opening new avenues for drug discovery services. The drug discovery services market is further supported by strategic collaborations, increased focus on emerging therapeutic areas, and the demand for high-quality, tailored solutions in the drug development process.

Drug Discovery Services Market Report Highlights

Lead optimization is the fastest growing segment in the drug discovery services market, driven by the increasing focus on refining drug candidates for improved efficacy and safety before clinical trials. Also, target selection segment continues to dominate, as it is crucial for identifying the most promising therapeutic targets in the early stages of drug discovery.
Chemistry services holds the largest market share, providing essential support in drug synthesis, optimization, and early-stage testing. Biology services is also the fastest growing segment due to the rising demand for biologics and personalized medicine, where biological insights are critical.
Pharmaceutical & biotechnology companies dominate the market, as they invest heavily in drug discovery to develop new treatments. Moreover, academic institutes segment are registering the fastest growth due to increased collaboration with industry players and growing research funding.
North America holds the largest drug discovery services market share, driven by its well-established pharmaceutical sector and technological advancements. Asia Pacific is the fastest growing region, fueled by rising investments in healthcare infrastructure and the increasing trend of outsourcing drug discovery services to cost-effective countries.
Key players in the drug discovery services market include companies such as Charles River Laboratories International, Inc.; Covance Inc. (now part of Labcorp); ICON plc; Syngene International Ltd.; WuXi AppTec Co., Ltd.; Pharmaceutical Product Development, LLC (PPD, now part of Thermo Fisher Scientific); Eurofins Scientific; GVK Biosciences; Jubilant Biosys, Evotec SE; Medpace Holdings, Inc.; TCG Lifesciences; Pharmaron Beijing Co., Ltd.; Frontage Laboratories, Inc.; and Selvita S.A.

Polaris Market Research has segmented drug discovery services market report on basis of process, type, end user, and region:

By Process Outlook (Revenue-USD Billion, 2020-2034)

Target Selection
Target Validation
Hit-To-Lead Identification
Lead Optimization
Candidate Validation

By Type Outlook (Revenue-USD Billion, 2020-2034)

Chemistry Services
Biology Services

By End User Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical & Biotechnology Companies
Academic Institutes
Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM3920

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Drug Discovery Services Market Insights

4.1. Drug Discovery Services Market - Market Snapshot
4.2. Drug Discovery Services Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Demand for Outsourcing Research Activities
  - 4.2.1.2. Rising Prevalence of Chronic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Costs of Drug Discovery
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Discovery Services Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Services Market, by Process

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
5.3. Target Selection
- 5.3.1. Global Drug Discovery Services Market, by Target Selection, by Region, 2020-2034 (USD Billion)
5.4. Target Validation
- 5.4.1. Global Drug Discovery Services Market, by Target Validation, by Region, 2020-2034 (USD Billion)
5.5. Hit-To-Lead Identification
- 5.5.1. Global Drug Discovery Services Market, by Hit-To-Lead Identification, by Region, 2020-2034 (USD Billion)
5.6. Lead Optimization
- 5.6.1. Global Drug Discovery Services Market, by Lead Optimization, by Region, 2020-2034 (USD Billion)
5.7. Candidate Validation
- 5.7.1. Global Drug Discovery Services Market, by Candidate Validation, by Region, 2020-2034 (USD Billion)

6. Global Drug Discovery Services Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
6.3. Chemistry Services
- 6.3.1. Global Drug Discovery Services Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
6.4. Biology Services
- 6.4.1. Global Drug Discovery Services Market, by Biology Services, by Region, 2020-2034 (USD Billion)

7. Global Drug Discovery Services Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
7.3. Pharmaceutical & Biotechnology Companies
- 7.3.1. Global Drug Discovery Services Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
7.4. Academic Institutes
- 7.4.1. Global Drug Discovery Services Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Drug Discovery Services Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Discovery Services Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Drug Discovery Services Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Drug Discovery Services Market - North America
- 8.3.1. North America: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
- 8.3.2. North America: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
- 8.3.3. North America: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Drug Discovery Services Market - U.S.
  - 8.3.4.1. U.S.: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Drug Discovery Services Market - Canada
  - 8.3.5.1. Canada: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
8.4. Drug Discovery Services Market - Europe
- 8.4.1. Europe: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
- 8.4.2. Europe: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
- 8.4.3. Europe: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Drug Discovery Services Market - UK
  - 8.4.4.1. UK: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Drug Discovery Services Market - France
  - 8.4.5.1. France: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Drug Discovery Services Market - Germany
  - 8.4.6.1. Germany: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Drug Discovery Services Market - Italy
  - 8.4.7.1. Italy: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Drug Discovery Services Market - Spain
  - 8.4.8.1. Spain: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Drug Discovery Services Market - Netherlands
  - 8.4.9.1. Netherlands: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Drug Discovery Services Market - Russia
  - 8.4.10.1. Russia: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Drug Discovery Services Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
8.5. Drug Discovery Services Market - Asia Pacific
- 8.5.1. Asia Pacific: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Drug Discovery Services Market - China
  - 8.5.4.1. China: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Drug Discovery Services Market - India
  - 8.5.5.1. India: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Drug Discovery Services Market - Malaysia
  - 8.5.6.1. Malaysia: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Drug Discovery Services Market - Japan
  - 8.5.7.1. Japan: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Drug Discovery Services Market - Indonesia
  - 8.5.8.1. Indonesia: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Drug Discovery Services Market - South Korea
  - 8.5.9.1. South Korea: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Drug Discovery Services Market - Australia
  - 8.5.10.1. Australia: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Drug Discovery Services Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
8.6. Drug Discovery Services Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Drug Discovery Services Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Drug Discovery Services Market - UAE
  - 8.6.5.1. UAE: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Drug Discovery Services Market - Israel
  - 8.6.6.1. Israel: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Drug Discovery Services Market - South Africa
  - 8.6.7.1. South Africa: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Drug Discovery Services Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
8.7. Drug Discovery Services Market - Latin America
- 8.7.1. Latin America: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Drug Discovery Services Market - Mexico
  - 8.7.4.1. Mexico: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Drug Discovery Services Market - Brazil
  - 8.7.5.1. Brazil: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Drug Discovery Services Market - Argentina
  - 8.7.6.1. Argentina: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Drug Discovery Services Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Drug Discovery Services Market, by Process, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Drug Discovery Services Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Drug Discovery Services Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Charles River Laboratories International, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Covance Inc. (part of Labcorp)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. ICON plc
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Syngene International Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. WuXi AppTec Co., Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher Scientific)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Eurofins Scientific
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. GVK Biosciences
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Jubilant Biosys
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Evotec SE
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development